|
|
|
|
|
T O P S T O R I E S |
|
ToxIC SCANNED Receives Renewed ONDCP FundingThe White House Office of National Drug Control Policy (ONDCP) has awarded a cooperative agreement to the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) to support the Substance Checking and ANalysis of New and Evolving Drugs (SCANNED) Overdose Surveillance Program. This marks the second year of funding for the project and will expand surveillance efforts to identify emerging drugs, inform prevention, and guide evidence-based policy.
SCANNED evaluates drug patterns identified in biological specimens collected from emergency department patients and compares these findings with substances identified in drug materials and fatal overdose data. These efforts help advance understanding of the rapidly evolving illicit drug supply. In the upcoming year, patient interviews will be implemented at a subset of participating emergency departments to gather information on drug use patterns, previous overdoses, and substance use disorder treatment history.
|
|
#NACCT2026 ACMT Pre-Symposium | Fungus Among Us: Updates in the Toxicology of Mushroom PoisoningWednesday, October 21, 2026 Town and Country Resort, San Diego, CA
Join ACMT at the 2026 North American Congress of Clinical Toxicology (NACCT) for our pre-symposium on October 21!
This will be an engaging full-day pre-symposium examining key aspects of mushroom toxicology, including basic science, foraging mix ups, updates on novel mechanisms of toxicity, emerging clinical syndromes, evolving regulation on cultivated psychoactive mushrooms, and a focus on incorporating lessons from several recent mushroom poisoning outbreaks—including death cap cases—to highlight challenges in clinical recognition and public health response.
|
|
New ToxIC DOTS PublicationA new study from the ToxIC Drug Overdose Toxico-Surveillance (DOTS) Reporting Program was published online in Public Health Reports. Drawing on data from 995 patients across 17 U.S. medical centers, the study demonstrates how patient interviews, medical record reviews, and comprehensive blood toxicology testing can strengthen surveillance of severe opioid and stimulant overdoses. Notably, fentanyl was detected in nearly two-thirds of patients who reported using only stimulants highlighting the limitations of relying solely on self-reported drug use or clinical presentation.
|
|
|
|
New ToxIC NOSE Brief: Cychloriphine: An Emerging OpioidThe latest ToxIC Novel Opioid and Stimulant Exposures (NOSE) Report highlights cychlorphine, an emerging non-fentanyl synthetic opioid, through a naloxone-responsive overdose in a patient who did not know she had taken an opioid. The case highlights the importance of treating suspected opioid toxicity based on clinical findings, even when routine fentanyl and opiate screens are negative.
|
|
|
|
ACMT Speaks at ONDCP Emerging Threats Committee MeetingACMT Executive Director Dr. Paul Wax was invited to speak at the Office of National Drug Control Policy's Emerging Threats Committee Meeting on Polysubstance use, where he shared some recent findings from ToxIC's projects. ToxIC also presented year 1 findings of the ToxIC SCANNED (Substance Checking and Analysis of New and Evolving Drugs) Program to a wider audience at ONDCP. |
|
|
|
Total Tox Course: Registration OpenRegistration for the 2026 ACMT Total Tox Course is now open! Join us for the ultimate virtual toxicology learning experience with the new and improved ACMT Total Tox Course running in early December on the 3-4 & 10-11, 2026!
Designed for healthcare professionals, this comprehensive virtual event provides cutting-edge knowledge and practical skills across pharmaceuticals, resources for the poisoned patient, substance use, alcohols, emergency and environmental preparedness, and non-pharmaceutical toxicology.
|
|
|
|
M E M B E R N E W S |
|
Congratulations on your new arrival!Please join us in congratulating ACMT member Kevin Baumgartner, MD and his family on the birth of their new baby. We are delighted to celebrate this special occasion and wish their growing family health, happiness, and many wonderful memories in the days ahead.
Congratulations to the family on this exciting new chapter!
|
|
|
|
Have something to share? We would love to hear from you! Whether its a new promotion, a publication, or a neat tox project you're working on, ACMT would love to hear about what our members are up to. Send us an email at communications@acmt.net and we may include your story in an upcoming newsletter! |
|
|
|
M E M B E R O P P O R T U N I T I E S |
|
Travel Awards Available for Medical Students, Residents & Future Medical ToxicologistsDEADLINE: October 12, 2026
Are you a medical student, resident, or trainee interested in medical toxicology? The Medical Toxicology Foundation (MTF) is offering several travel awards to help support attendance at the ACMT Annual Scientific Meeting.
Applications are now open for the Dr. Carol R. Angle Pediatric Toxicology Travel Award, Resident Travel Award, Dr. Michael Shannon Travel Award, and Johnson & Johnson Consumer Health Travel Award.
|
|
ANTIDOTE Institute: Research & Career Development OpportunitiesDEADLINE: November 6, 2026
The ANTIDOTE Institute, supported by the American College of Medical Toxicology (ACMT) and National Institute on Drug Abuse (NIDA), provides mentorship, research funding, grant development, and career guidance for medical toxicologists pursuing careers in research related to addiction, substance use, and health outcomes.
Three program paths are available: the FIT Program, the Full Program, and the Alumni Supplemental Award (available to current or past ANTIDOTE participants). Please view the ANTIDOTE webpage for more details on the specific requirements for these programs.
|
|
Applications Open for the February 2027 Medical Toxicology in Industry RotationDEADLINE: November 23, 2026
Applications are now open for the February 2027 Medical Toxicology in Industry (MTI) Virtual Fellows Rotation Program! This is a four-week virtual rotation, hosted by Bayer in partnership with the Medical Toxicology Foundation. The goal is to teach the principles of product development from the R&D pipeline, through the regulatory process, to launch and post-market stewardship. The rotation will address the gap in understanding the role of industry and the regulatory oversight of bringing important technology from the academic arena to the public sphere.
Interested fellows should submit a one-page letter of interest, a letter of support from their Fellowship Director, and a current CV/resume. Visit the MTI Program page for application details and additional information.
|
|
S T A F F S P O T L I G H T |
|
|
Shaniyah Wrighton ACMT Webinar Coordinator |
|
Hometown: Wadmalaw Island, South Carolina
College: Francis Marion University
If you weren't in this field, what would you be doing? I would be traveling the globe as a professional harpist, playing in an orchestra.
Favorite medical-themed show, book, movie, etc.? My favorite medical-themed movie is Awakenings (1990). It still gets me every time!
What’s one thing you’re excited to learn at ACMT? One thing I'm especially excited to learn more about is how medical toxicologists approach the rapidly shifting landscape of substance exposures, particularly fentanyl and novel synthetic drugs. |
|
O C T O B E R C A L E N D A R |
|
|
|
Did you know? ACMT has merch! |
|
We have dozens of in-house illustrated Tox goodies up in our Zazzle storefront, conveniently made to order and shipped directly to you. Notebooks, mouse pads, water bottles, shirts and sweaters and much more -- a real toxicological bounty for you to explore!
We hope you'll check them out and find something you enjoy. |
|
|
|
J O B B O A R D |
|
If you are interested in posting to this board, please fill out the post request form.
|
|
|
|
© 2026 American College of Medical Toxicology |